Jönsson B - Search Results

1

Resource use and costs associated with patients treated for depression in primary care.

Sobocki P, Ekman M, Agren H, Krakau I, Runeson B, Mårtensson B, Jönsson B. Sobocki P, et al. Among authors: jonsson b. Eur J Health Econ. 2007 Mar;8(1):67-76. doi: 10.1007/s10198-006-0008-3. Eur J Health Econ. 2007. PMID: 17165073

2

The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression.

Sobocki P, Ekman M, Agren H, Runeson B, Jönsson B. Sobocki P, et al. Among authors: jonsson b. Int J Clin Pract. 2006 Jul;60(7):791-8. doi: 10.1111/j.1742-1241.2006.00997.x. Int J Clin Pract. 2006. PMID: 16846399

3

Cost effectiveness of bisoprolol in the treatment of chronic congestive heart failure in Sweden: analysis using data from the Cardiac Insufficiency Bisoprolol Study II trial.

Ekman M, Zethraeus N, Jönsson B. Ekman M, et al. Among authors: jonsson b. Pharmacoeconomics. 2001;19(9):901-16. doi: 10.2165/00019053-200119090-00002. Pharmacoeconomics. 2001. PMID: 11700777

4

Resource allocation to brain research in Europe (RABRE).

Sobocki P, Lekander I, Berwick S, Olesen J, Jönsson B. Sobocki P, et al. Among authors: jonsson b. Eur J Neurosci. 2006 Nov;24(10):2691-3. doi: 10.1111/j.1460-9568.2006.05116.x. Eur J Neurosci. 2006. PMID: 17156195

5

Brain research has high returns but Europe is lagging behind.

Sobocki P, Olesen J, Jönsson B. Sobocki P, et al. Among authors: jonsson b. Eur J Neurol. 2007 Jun;14(6):708-10. doi: 10.1111/j.1468-1331.2007.01816.x. Eur J Neurol. 2007. PMID: 17539958

6

The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder.

Sobocki P, Ekman M, Ovanfors A, Khandker R, Jönsson B. Sobocki P, et al. Among authors: jonsson b. Int J Clin Pract. 2008 Apr;62(4):623-32. doi: 10.1111/j.1742-1241.2008.01711.x. Epub 2008 Feb 15. Int J Clin Pract. 2008. PMID: 18284439 Free PMC article. Clinical Trial.

7

Cost effectiveness of cardiac resynchronization therapy in the Nordic region: an analysis based on the CARE-HF trial.

Blomström P, Ekman M, Lundqvist CB, Calvert MJ, Freemantle N, Lönnerholm S, Wikström G, Jönsson B. Blomström P, et al. Among authors: jonsson b. Eur J Heart Fail. 2008 Sep;10(9):869-77. doi: 10.1016/j.ejheart.2008.06.018. Epub 2008 Aug 5. Eur J Heart Fail. 2008. PMID: 18684664 Free article. Clinical Trial.

8

The burden of rheumatoid arthritis and access to treatment: uptake of new therapies.

Jönsson B, Kobelt G, Smolen J. Jönsson B, et al. Eur J Health Econ. 2008 Jan;8 Suppl 2:S61-86. doi: 10.1007/s10198-007-0089-7. Eur J Health Econ. 2008. PMID: 18097697

9

Cost of disorders of the brain in Italy.

Pugliatti M, Sobocki P, Beghi E, Pini S, Cassano GB, Altamura AC, Pozzoli S, Rosati G; Cost of Disorders of the Brain in Europe" Study Group. Pugliatti M, et al. Neurol Sci. 2008 Apr;29(2):99-107. doi: 10.1007/s10072-008-0868-7. Epub 2008 May 16. Neurol Sci. 2008. PMID: 18483707

10

Direct medical costs for patients with type 2 diabetes in Sweden.

Henriksson F, Agardh CD, Berne C, Bolinder J, Lönnqvist F, Stenström P, Ostenson CG, Jönsson B. Henriksson F, et al. Among authors: jonsson b. J Intern Med. 2000 Nov;248(5):387-96. doi: 10.1046/j.1365-2796.2000.00749.x. J Intern Med. 2000. PMID: 11123503 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,571 results

Search Page

Filters